NovoCure Ltd (NVCR)
14.77
+0.58
(+4.09%)
USD |
NASDAQ |
May 03, 16:00
14.77
0.00 (0.00%)
After-Hours: 20:00
NovoCure Cash from Operations (Quarterly): -14.56M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -14.56M |
| September 30, 2023 | -19.31M |
| June 30, 2023 | -22.74M |
| March 31, 2023 | -16.73M |
| December 31, 2022 | -3.707M |
| September 30, 2022 | 22.42M |
| June 30, 2022 | 15.76M |
| March 31, 2022 | -3.687M |
| December 31, 2021 | 14.40M |
| September 30, 2021 | 24.40M |
| June 30, 2021 | 26.17M |
| March 31, 2021 | 17.78M |
| December 31, 2020 | 53.48M |
| September 30, 2020 | 30.97M |
| June 30, 2020 | 12.74M |
| March 31, 2020 | 1.957M |
| December 31, 2019 | 6.962M |
| September 30, 2019 | 14.91M |
| Date | Value |
|---|---|
| June 30, 2019 | 9.066M |
| March 31, 2019 | -4.315M |
| December 31, 2018 | 16.81M |
| September 30, 2018 | 5.638M |
| June 30, 2018 | -7.493M |
| March 31, 2018 | -16.82M |
| December 31, 2017 | -2.898M |
| September 30, 2017 | 2.548M |
| June 30, 2017 | -5.876M |
| March 31, 2017 | -26.91M |
| December 31, 2016 | -13.72M |
| September 30, 2016 | -33.50M |
| June 30, 2016 | -29.39M |
| March 31, 2016 | -30.98M |
| December 31, 2015 | -26.12M |
| September 30, 2015 | -22.11M |
| June 30, 2015 | -23.19M |
| March 31, 2015 | -28.47M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-22.74M
Minimum
Jun 2023
53.48M
Maximum
Dec 2020
8.963M
Average
12.74M
Median
Jun 2020
Cash from Operations (Quarterly) Benchmarks
| AtriCure Inc | -21.02M |
| NeuroMetrix Inc | -1.450M |
| Repligen Corp | 44.71M |
| Teleflex Inc | 138.86M |
| Perspective Therapeutics Inc | -9.008M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 98.50M |
| Cash from Financing (Quarterly) | 1.91M |
| Free Cash Flow | -100.43M |
| Free Cash Flow Per Share (Quarterly) | -0.20 |
| Free Cash Flow to Equity (Quarterly) | -22.22M |
| Free Cash Flow to Firm (Quarterly) | -21.38M |
| Free Cash Flow Yield | -6.39% |